Skip to content

Screening Protocol for Adults With ADHD

A Screening Protocol for Adults With Attention Deficit Hyperactivity Disorder

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00592254
Enrollment
3000
Registered
2008-01-14
Start date
2002-12-31
Completion date
2023-12-31
Last updated
2022-01-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ADHD

Keywords

ADHD, Adults

Brief summary

The objective of this protocol is to establish a comprehensive screening process to evaluate the eligibility of potential adult subjects for appropriate ADHD clinical research studies

Detailed description

To address the needs of the large number of adults who contact the Adult ADHD Program at Massachusetts General Hospital annually, we have sought approval for several research studies aimed at evaluating critical components of the needs of this population. Potential participants for those studies present with a widely varied set of complaints not always discernable in a telephone screening interview. This state of affairs often makes it difficult to ask subjects to sign a specific protocol's consent form without obtaining additional clinical information. Because of this, we have potential subjects consent to undergo an in-depth clinical assessment that will allow them to be screened by a clinician for eligibility to a diverse clinical research program available to them.

Interventions

None listed

Sponsors

Massachusetts General Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 55 Years
Healthy volunteers
No

Inclusion criteria

1. Males and females ages 18-55 2. Subjects must have a DSM-IV or DSM-V diagnosis of ADHD, as determined by a clinical evaluation based on DSM-IV or DSM-V criteria

Exclusion criteria

1. History of head trauma with loss of consciousness, organic brain disorders, seizures, or neurosurgical intervention. 2. Any significant medical condition, in the judgment of the investigator 3. Mental retardation 4. Pregnancy of lactation 5. Subjects with a known recent history (within the past 6 months) of illicit drug or alcohol dependence 6. Sensory difficulties such as deafness or blindness

Design outcomes

Primary

MeasureTime frameDescription
Screening ProtocolSreeningThis study is a prescreening for possible entry into other studies

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026